Sight Sciences CFO sells 6,902 shares for taxes

Sight Sciences Chief Financial Officer James Rodberg reported an open-market sale of 6,902 shares of common stock on July 2, 2026 at a weighted average price of $5.36 per share, in transactions ranging from $5.19 to $5.46.

Rhea-AI Filing Summary

Sight Sciences Chief Financial Officer James Rodberg reported an open-market sale of 6,902 shares of common stock on July 2, 2026 at a weighted average price of $5.36 per share, in transactions ranging from $5.19 to $5.46. According to the footnotes, these shares were sold to cover his tax liability arising from the vesting of restricted stock units. Following the sale, he beneficially owns 224,037 shares, including 55,200 shares of common stock and 168,837 shares that will be acquired upon future vesting and settlement of RSUs.

Insider Trade Summary 10b5-1

Net Seller: 6,902 shares

Net Sell 1 txn

Insider Rodberg James

Role Chief Financial Officer

Sold 6,902 shs ($37K)

Type	Security	Shares	Price	Value
Sale	Common Stock	6,902	$5.36	$37K

Holdings After Transaction: Common Stock — 224,037 shares (Direct)

Footnotes (3)

1. F1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").
2. F2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.19 to $5.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. Includes (i) 55,200 shares of Common Stock, and (ii) 168,837 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

Key Figures

Shares sold: 6,902 shares Weighted average sale price: $5.36 per share Sale price range: $5.19–$5.46 per share +3 more

6 metrics

Shares sold 6,902 shares Open-market sale on July 2, 2026

Weighted average sale price $5.36 per share Common stock sale to cover tax liability

Sale price range $5.19–$5.46 per share Multiple transactions within this range

Shares owned after transaction 224,037 shares Total beneficial ownership following sale

Current common shares held 55,200 shares Portion of total beneficial ownership

Unvested RSU-linked shares 168,837 shares To be acquired upon RSU vesting and settlement

Key Terms

restricted stock units, weighted average price, vesting and settlement, open-market sale

4 terms

restricted stock units financial

"in connection with the vesting of restricted stock units ("RSUs")."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

weighted average price financial

"Reflects the weighted average price at which the shares of Common Stock were sold."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

vesting and settlement financial

"shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested."

open-market sale financial

"Sale in open market or private transaction"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Sight Sciences (SGHT) report for CFO James Rodberg?

Sight Sciences reported that CFO James Rodberg sold 6,902 shares of common stock. The sale occurred on July 2, 2026, as an open-market transaction primarily to cover tax obligations related to the vesting of his restricted stock units.

At what prices did the Sight Sciences (SGHT) CFO sell his 6,902 shares?

The 6,902 Sight Sciences shares were sold at a weighted average price of $5.36 per share. Individual trades occurred in multiple transactions within a price range from $5.19 to $5.46, according to the footnote disclosure in the filing.

Why did Sight Sciences (SGHT) CFO James Rodberg sell shares in this Form 4 filing?

The CFO sold shares to cover his tax liability from vesting restricted stock units. This type of sale is a common, mechanical step when equity awards vest, allowing the insider to satisfy income tax obligations without using separate cash.

How many Sight Sciences (SGHT) shares does the CFO hold after the reported sale?

After the transaction, the CFO beneficially owns 224,037 shares. This total includes 55,200 shares of common stock already held and 168,837 additional shares that are scheduled to be received as existing RSUs continue to vest and settle over time.

Is the Sight Sciences (SGHT) CFO’s sale considered an open-market transaction?

Yes, the Form 4 identifies the transaction as an open-market sale of common stock. However, the filing explains that the purpose was to cover taxes from RSU vesting, distinguishing it from a discretionary sale driven by a change in the insider’s investment outlook.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 07:36 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rodberg James

(Last) (First) (Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK CALIFORNIA 94025

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/02/2026		S		6,902(1)	D	$5.36(2)	224,037(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").

2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.19 to $5.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Includes (i) 55,200 shares of Common Stock, and (ii) 168,837 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

	/s/Jeremy Hayden, Attorney-in-Fact for James Rodberg	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)